Hepatitis a seroprevalence among infants aged 12 months in ankara

Turkish Journal of Pediatrics

Volumn 53, Issue 1, 2011, Pages 114-116

  Ince, Osman Tolga ^a   Songul Yalcin S ^a   Yurdakök, Kadriye ^a   Özmert, Elif N ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Hepatitis a; Seroprevalence

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; MATERNAL ANTIBODY;

ARTICLE; FEMALE; HEPATITIS A; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEX DIFFERENCE; TURKEY (REPUBLIC); VACCINATION; EPIDEMIOLOGY;

FEMALE; HEPATITIS A; HUMANS; INFANT; MALE; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 79958697785     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ceyhan M, Yildirim I, Kurt N, et al. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat 2008; l5: 69-72.
2. Sidal M, Ünüvar E, Oǧuz F, et al. Age-specific seroepidemiology of hepatitis A, B and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17: 141-144.
3. Kanra G, Tezcan S, Badur S, and Turkish National Study Team. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002; 44: 204-210.
4. Tanir G, Kiliçarslan F, Göl N, Arslan Z. Age-specific seroprevalence and associated risk factors for hepatitis A in children in Ankara, Turkey. J Ankara Medical School 2003; 25: 81-88.
5. Tosun S, Ertan P, Kasirga E, Atman U. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediatr Int 2004; 46: 669-672.
6. Alabaz D, Aksaray N, Alhan E, Yaman A. Decline of maternal hepatitis A antibodies during the first two years of life in infants born in Turkey. Am J Trop Med Hyg 2005; 73: 457-459.
7. Özen M, Yoloǧlu S, Işik Y, Tekerekoǧlu MS. Turgut Özal Ti{dotless}p Merkezi'ne başvuran 2-16 yaş grubundaki çocuklarda anti-HAV IgG seropozitifliǧi. Türk Pediatri Arşivi 2006; 41: 36-40.
8. Arabaci F, Oldacay M. The seroprevalence of hepatitis A in different age groups and hepatitis A incidence in acute hepatitis cases in the Canakkale Province. J Pediatr Infect 2009; 3: 58-60.
9. World Health Organization. Hepatitis A vaccines: WHO position paper. Wkly Epidemiol Rec 2000; 75: 38-44.
10. American Academy of Pediatrics. Hepatitis A. In: Pickering LK, Baker CJ, Long SS, McMillan JA (eds). Red Book: 2006 Report of the Committee on Infectious Diseases (27th ed). Elk Grove Village, IL: American Academy of Pediatrics; 2006: 326-335.
11. Vidor E. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies. J Comp Path 2007; 137: 42-45.
12. Lieberman JM, Chang S, Partridge S, et al. Kinetics of maternal hepatitis A antibody decay in infants: implications for vaccine use. Pediatr Infect Dis J 2002; 21: 347-348.